Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease.
Carlsson CM, Gleason CE, Hess TM, Moreland KA, Blazel HM, Koscik RL, Schreiber NT, Johnson SC, Atwood CS, Puglielli L, Hermann BP, McBride PE, Stein JH, Sager MA, Asthana S.
Carlsson CM, et al. Among authors: sager ma.
J Alzheimers Dis. 2008 Mar;13(2):187-97. doi: 10.3233/jad-2008-13209.
J Alzheimers Dis. 2008.
PMID: 18376061
Clinical Trial.